What Researchers Did
Researchers reported on two patients with idiopathic sudden sensorineural hearing loss (ISSHL) who received adjunctive hyperbaric oxygen therapy (HBO2) and steroid injections.
What They Found
Both patients, treated with a standard 2.4 atmospheres absolute (atm abs) 90-minute HBO2 protocol, showed positive outcomes. They experienced significantly improved scores in both speech reception and speech discrimination.
What This Means for Canadian Patients
For Canadian patients experiencing idiopathic sudden sensorineural hearing loss, adjunctive hyperbaric oxygen therapy might be considered as a potential treatment option. However, further robust research is needed to establish its widespread efficacy and availability.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.
Study Limitations
A significant limitation of this study is its design as a case report involving only two patients, which severely limits the generalizability of the findings.